Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 11.02.2025
Cherry SE
Munich, 11 February 2025 - Subdued trends in the Americas and increasing competitive disadvantages in the switch business are weighing on Group revenue in the fourth quarter of 2024. According to the current state of assessment, Cherry SE's annual revenue for 2024 is therefore below the forecast of around EUR 120 million. The profound structural ad [ … ]
Tue, 11.02.2025
vVardis AG
ZUG, SWITZERLAND, February 11, 2025 – vVARDIS, a Swiss high growth dental company, and OrbiMed, a leading healthcare investment firm, today announced the closing of a $35 million financing. The capital will support the company’s growth initiatives and global commercial expansion. vVARDIS is a developer and manufacturer of unique dental products und [ … ]
Tue, 11.02.2025
Cherry SE
Munich, 11 February 2024 - According to preliminary and as yet unaudited figures for the financial year 2024, Group revenue and the adjusted Group EBITDA margin* will not reach the forecast last updated on October 22, 2024. In 2024 as a whole, Group revenue is expected to amount to around EUR 110 million (forecast: around EUR 120 million) and the a [ … ]
Tue, 11.02.2025
Nakiki SE
- Share capital to be increased from EUR 5,722.495 to up to EUR 6,220,103 against cash contributions
- Subscription price of EUR 1.00 per share for up to 497,608 New Shares
- Unsubscribed New Shares to be offered in a private placement
Frankfurt am Main, February 11, 2025 - The Management Board of Nakiki SE (“Company”; ISIN: DE000WNDL300; ISIN: DE [ … ]
Tue, 11.02.2025
Salzgitter Aktiengesellschaft
According to the still preliminary figures now available, the Salzgitter Group recorded the following results in the financial year 2024: external sales of € 10.0 billion (FY 2023: € 10.8 billion), earnings before interest, taxes, depreciation and amortization (EBITDA) of € 445 million (FY 2023: € 677 million) and a pre-tax loss of € -296 million ( [ … ]
Tue, 11.02.2025
SANHA GmbH & Co. KG
NOT FOR DISTRIBUTION, PUBLICATION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION, PUBLICATION OR TRANSMISSION WOULD BE UNLAWFUL
SANHA GmbH & Co. KG is repaying the 2013/2026 corporate bond early as of 15 Marc [ … ]
Tue, 11.02.2025
ADS-TEC Energy GmbH
EQS-Media / 11.02.2025 / 14:30 CET/CEST
ADS-TEC Energy Reports Strong Earnings Improvement for 2024 on Preliminary Results and Announces Strategic Business Expansion
Key Highlights:
Significant Earnings Improvement – Achieved important improvement in earnings and reported positive gross profit for the first time, despite a highly volatile [ … ]
Tue, 11.02.2025
urban-gro, Inc
Company Name:
urban-gro, Inc
ISIN:
US91704K2024
Reason for the research:
Update
Recommendation:
Kaufen
from:
11.02.2025
Target price:
$4,70
Target price on sight of:
12 Monate
Last rating change:
-
Analyst:
Ellis Acklin
First Berlin Equity Research hat ein Research Update zu urban-gro, Inc. (ISIN: US91704K2024) veröffentl [ … ]
Tue, 11.02.2025
Highlight Communications AG
Publication of inside information pursuant to Article 17 MAR
Pratteln, 11 February 2024
TEAM's bid in the UEFA club competitions tender process for the 2027 - 2033 seasons remains unconsidered
UC3, the joint venture company between UEFA and the European Club Association (ECA), has informed TEAM Marketing AG ("TEAM"), a subsidiary of Highlight Co [ … ]
Tue, 11.02.2025
Mainz BioMed N.V.
Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness MonthUpdated Screening Guidelines Ensure Broader Access to Colorectal Cancer Screening in Germany
BERKELEY, US and MAINZ, Germany – February 11, 2025 -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genet [ … ]